
At CDMO Live Europe 2026, Dr. Olivier Aebischer, Deputy CEO at Interlabor Belp AG, demonstrated how a structured, dual-path analytical approach can identify manufacturing root causes in days, using two real contamination case studies from the lab’s operations.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

What CDMOs Get Wrong About AI for Bioprocessing, According to Sapiens Health’s Seungik Cho

How ExoZymes Is Running a 10-CDMO RFP for CDMO Selection

How EU Sustainability Regulations Are Reshaping CDMO Manufacturing

"Stop Talking About Resilience in the Future Tense": What Pharma Actually Wants From CDMOs
Free AI-powered recaps of PharmaSource Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.